Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere®

NCT03203837

NULLOBSERVATIONAL

Northwestern University

4 participants

Started 2017-07-05 · Completed 2020-01-06

Status: Terminated (as of 12-23-2025)

Conditions

Hepatocellular Carcinoma

Interventions

OTHER: Plasma collection

Linked Papers (from SciSciNet-V2)

Total Papers29

Background

11

Result

0

Derived

0

Unknown

18

View on ClinicalTrials.gov

Total Citations Per Year

Brief Summary

To analyze specific angiogenic, inflammatory and immune profiles in hepatocellular carcinoma patients who undergo radioembolization.

Sort by:

Background Papers22

Hepatocellular carcinoma: clinical frontiers and perspectives

1,265 citations

Hepatocellular carcinoma: clinical frontiers and perspectives

1,265 citations

Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection

Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study

Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study

Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma

Upregulation of Circulating PD-L1/PD-1 Is Associated with Poor Post-Cryoablation Prognosis in Patients with HBV-Related Hepatocellular Carcinoma

Nuclear β-Catenin Induces an Early Liver Progenitor Phenotype in Hepatocellular Carcinoma and Promotes Tumor Recurrence

Nuclear β-Catenin Induces an Early Liver Progenitor Phenotype in Hepatocellular Carcinoma and Promotes Tumor Recurrence

Tumor necrosis factor-alpha-308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients

Tumor necrosis factor-alpha-308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients

The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma

The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma

Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B

Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked

Unknown Papers18

Complex networks orchestrate epithelial–mesenchymal transitions

3,818 citations

Distinct Role of Macrophages in Different Tumor Microenvironments

2,130 citations

Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes

1,473 citations

Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6

Prognostic molecular markers in hepatocellular carcinoma: A systematic review

Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis

Hypoxia and platelet‐derived growth factor‐BB synergistically upregulate the expression of vascular endothelial growth factor in vascular smooth muscle cells

Prognostic significance of pathologic features of hepatocellular carcinoma a multivariate analysis of 278 patients

Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C.

Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin‐2 and hypoxia‐induced factor‐1a

Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: Effect of viremia levels and antiviral treatment

Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma

Down-Regulation of Hedgehog-Interacting Protein through Genetic and Epigenetic Alterations in Human Hepatocellular Carcinoma

Possible contribution of circulating transforming growth factor‐β1 to immunity and prognosis in unresectable hepatocellular carcinoma

Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours

Alterations of oncogenes, tumor suppressor genes and growth factors in hepatocellular carcinoma: with relation to tumor size and invasiveness.

In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells

Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.